Axa S.A. Ptc Therapeutics, Inc. Transaction History

Axa S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$46.8 - $68.92 $772,200 - $1.14 Million	-16,500 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$45.41 - $57.07 $13,622 - $17,121	-300 Reduced 1.79%	16,500 $771,000
Q2 2020 Aug 14, 2020	BUY	$42.56 - $54.98 $715,008 - $923,664	16,800 New	16,800 $852,000
Q1 2018 May 14, 2018	SELL	$17.46 - $32.59 $1.2 Million - $2.24 Million	-68,700 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$15.14 - $20.89 $979,558 - $1.35 Million	-64,700 Reduced 48.5%	68,700 $1.15 Million

Q3 2017 Nov 13, 2017	BUY	$16.81 - $21.61 $2.24 Million - $2.88 Million	133,400	133,400 $2.67 Million

198

83.7M

192K

129K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.17B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.